نتایج جستجو برای: pla2

تعداد نتایج: 1363  

Journal: :Clinical chemistry 1992
T J Nevalainen P T Kortesuo E Rintala F Märki

Time-resolved fluoroimmunoassay was developed for the detection of synovial-type phospholipase A2 (s-PLA2) in human serum. This solid-phase, sandwich assay uses a polyclonal rabbit antibody raised against synovial-type group II PLA2 produced in Escherichia coli. No cross-reactions were detected between s-PLA2 and PLA2 from human or porcine pancreas, human ascitic fluid, or bee or cobra venom. I...

Journal: :Gut 1997
W Uhl H J Schrag N Schmitter T J Nevalainen J Aufenanger A M Wheatley M W Büchler

BACKGROUND In human acute pancreatitis two different types of secretory phospholipase A2 (PLA2) have been found. AIM To analyse the specific pattern of distribution of these PLA2 activities and their pathophysiological role in experimental acute pancreatitis. SUBJECTS AND METHODS Catalytic activities of secretory type I (pancreatic) and type II (non-pancreatic) PLA2 and the protein concentr...

Journal: :Infection and immunity 2000
V J Laine D S Grass T J Nevalainen

Group II phospholipase A2 (PLA2) is a newly recognized antibacterial acute-phase protein. Recently we observed that transgenic mice expressing group II PLA2 (PLA2(+) mice) were able to resist experimental Staphylococcus aureus infection by killing the bacteria, as indicated by improved survival and by the small numbers of live bacteria in their tissues (V. J. O. Laine, D. S. Grass, and T. J. Ne...

Journal: :Gut 1995
I Lilja K Smedh G Olaison R Sjödahl C Tagesson C Gustafson-Svärd

Increased activity of phospholipase A2 (PLA2) in the ileal mucosa may contribute to the inflammation in Crohn's disease. The results of this study showed that (a) three months after ileocolonic resection for Crohn's disease the neoterminal ileal mucosa showed endoscopically new inflammation and had higher PLA2 activity than at the time of the operation (n = 8); no such findings were seen in con...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2007
Margaretha Persson Bo Hedblad Jeanenne J Nelson Göran Berglund

BACKGROUND To explore potential interrelationships between lipoprotein-associated phospholipase A2 (Lp-PLA2), the metabolic syndrome (MetS), and incident cardiovascular disease (CVD). METHODS AND RESULTS MetS was defined by the National Cholesterol Education Program Adult treatment Panel III criteria in 4480 nondiabetic Malmö Diet and Cancer Study subjects without history of CVD. Incidence of...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 1991
G Rordorf Y Uemura J V Bonventre

Brain phospholipase A2 (PLA2) activity has not been well characterized. Given the importance of this enzymatic activity for a variety of cellular functions in the brain, we characterized the subcellular distribution of PLA2 activity in gerbil brain and evaluated how PLA2 activity was altered by ischemia and reperfusion. Cytosolic, mitochondrial, and microsomal fractions were prepared by differe...

Journal: :Gut 1994
T Minami H Tojo Y Shinomura Y Matsuzawa M Okamoto

The immunochemical protein content of group II phospholipase A2 (PLA2) and PLA2 enzymatic activity were measured for colonic mucosal biopsy samples obtained from patients with either Crohn's disease of the colon or ulcerative colitis, and control patients without inflammatory bowel disease. Immunoreactive group II PLA2 (IR-PLA2 II) content and PLA2 activity in actively inflamed colonic mucosa o...

Journal: :The Journal of clinical investigation 1993
M Konieczkowski J R Sedor

IL-1 stimulates mesangial cells to synthesize specific proteins, including a non-pancreatic (Type II) phospholipase A2 (PLA2). We have studied the regulation of PLA2 by proinflammatory mediators, implicated in the pathogenesis of glomerulonephritis, and have assessed whether the activation of second messenger systems modulates or mimics PLA2 gene expression by cytokines. IL-1 alpha and beta, TN...

Journal: :Clinical chemistry 1993
T J Nevalainen

Phospholipase A2 (EC 3.1.1.4; PLA2) is detected in serum by determination of either the catalytic activity of the enzyme or the concentration of the enzyme protein by immunoassays. The most sensitive methods for determining PLA2 catalytic activity are radiometric assays, with a substrate of synthetic phospholipid (e.g., phosphatidylcholine or phosphatidylethanolamine) containing a 14C- or 3H-la...

2016
Lars Wallentin Claes Held Paul W. Armstrong Christopher P. Cannon Richard Y. Davies Christopher B. Granger Emil Hagström Robert A. Harrington Judith S. Hochman Wolfgang Koenig Sue Krug‐Gourley Emile R. Mohler Agneta Siegbahn Elizabeth Tarka Philippe Gabriel Steg Ralph A. H. Stewart Robert Weiss Ollie Östlund Harvey D. White Andrzej Budaj Diego Ardissino Alvaro Avezum Philip E. Aylward Alfonso Bryce Hong Chen Ming‐Fong Chen Ramon Corbalan Anthony J. Dalby Nicolas Danchin Robbert J. De Winter Stefan Denchev Rafael Diaz Moses Elisaf Marcus D. Flather Assen R. Goudev Liliana Grinfeld Steen Husted Hyo‐Soo Kim Ales Linhart Eva Lonn José López‐Sendón Athanasios J. Manolis José C. Nicolau Prem Pais Alexander Parkhomenko Terje R. Pedersen Daniel Pella Marco A. Ramos‐Corrales Mikhail Ruda Mátyás Sereg Saulat Siddique Peter Sinnaeve Piyamitr Sritara Henk P. Swart Rody G. Sy Tamio Teramoto Hung‐Fat Tse W. Douglas Weaver Margus Viigimaa Dragos Vinereanu Junren Zhu

BACKGROUND We evaluated lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in patients with stable coronary heart disease before and during treatment with darapladib, a selective Lp-PLA2 inhibitor, in relation to outcomes and the effects of darapladib in the STABILITY trial. METHODS AND RESULTS Plasma Lp-PLA2 activity was determined at baseline (n=14 500); at 1 month (n=13 709); seria...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید